What is the ticker symbol for XORTX Therapeutics?

XORTX Therapeutics trades under the ticker XRTX on NASDAQ.

What sector does XORTX Therapeutics operate in?

XORTX Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze XRTX in a portfolio?

PortView shows XRTX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

XORTX Therapeutics (XRTX) Stock Analysis

NASDAQHealthcareBiotechnology

$2.18+0.93%

1-year price historyRange $1.73 – $5.50

52-week range$2.18

$1.73$7.05

What XORTX Therapeutics does

XORTX Therapeutics Inc. is a biopharmaceutical firm dedicated to advancing and bringing to market medical treatments targeting a range of conditions, including chronic kidney ailments, diabetes, insulin resistance, metabolic syndrome, diabetic nephropathy, and various infections. Their pipeline includes XRx-008, a late-stage clinical program designed to address autosomal dominant polycystic kidney disease (ADPKD). Another key candidate is XRx-101, an agent aimed at reducing uric acid levels in COVID-19 patients, with the goal of mitigating acute kidney injury and related complications. Furthermore, they are developing XRx-221, a series of xanthine oxidase inhibitors intended for the management of diabetic nephropathy. XORTX also collaborates with the Icahn School of Medicine on research investigating acute kidney injury and hyperuricemia among hospitalized COVID-19 patients. The company's operations are headquartered in Vancouver, Canada.

Key metrics

Market cap

$607,106

P/E (TTM)

-0.80

EPS (TTM)

$-2.73

Beta

0.08

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$2.11

200-day avg

$2.41

52-week high

$7.05

52-week low

$1.73

CEO

Allen Warren Davidoff

ETFs linked to XRTX

Broad-market and Healthcare sector ETFs an investor holding XORTX Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how XRTX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze XRTX in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for XORTX Therapeutics?: XORTX Therapeutics trades under the ticker XRTX on NASDAQ.
Which exchange is XRTX listed on?: XRTX is listed on NASDAQ.
What sector does XORTX Therapeutics operate in?: XORTX Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze XRTX in a portfolio?: PortView shows XRTX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.